Sotera Health Company (SHC)
USD 13.2
(0.92%)
USD 13.2
(0.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 577.15 Million USD | -7.84% |
| 2022 | 557 Million USD | 7.39% |
| 2021 | 518.67 Million USD | 16.93% |
| 2020 | 443.57 Million USD | 12.17% |
| 2019 | 395.43 Million USD | 10.69% |
| 2018 | 357.25 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 137.37 Million USD | 23.33% |
| 2024 Q3 | 158.02 Million USD | 15.03% |
| 2024 Q1 | 111.38 Million USD | -32.24% |
| 2023 Q3 | 145.98 Million USD | 4.58% |
| 2023 FY | 513.35 Million USD | -7.84% |
| 2023 Q4 | 164.38 Million USD | 12.6% |
| 2023 Q1 | 111.5 Million USD | -21.32% |
| 2023 Q2 | 139.58 Million USD | 25.19% |
| 2022 Q4 | 141.72 Million USD | 4.2% |
| 2022 FY | 557 Million USD | 7.39% |
| 2022 Q1 | 128.87 Million USD | -3.79% |
| 2022 Q3 | 136.01 Million USD | -9.56% |
| 2022 Q2 | 150.39 Million USD | 16.7% |
| 2021 Q1 | 115.37 Million USD | -4.32% |
| 2021 FY | 518.67 Million USD | 16.93% |
| 2021 Q4 | 133.95 Million USD | 6.66% |
| 2021 Q3 | 125.58 Million USD | -12.64% |
| 2021 Q2 | 143.76 Million USD | 24.61% |
| 2020 Q4 | 120.57 Million USD | 12.15% |
| 2020 Q3 | 107.51 Million USD | -9.63% |
| 2020 Q2 | 118.96 Million USD | 23.26% |
| 2020 Q1 | 96.51 Million USD | -0.72% |
| 2020 FY | 443.57 Million USD | 12.17% |
| 2019 Q3 | 100.24 Million USD | 1.27% |
| 2019 FY | 395.43 Million USD | 10.69% |
| 2019 Q1 | 98.98 Million USD | 0.0% |
| 2019 Q2 | 98.98 Million USD | 0.0% |
| 2019 Q4 | 97.22 Million USD | -3.02% |
| 2018 FY | 357.25 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -5933.431% |
| Prenetics Global Limited | 8.82 Million USD | -6436.414% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -4739.494% |
| CareDx, Inc | 178.32 Million USD | -223.655% |
| Exact Sciences Corporation | 1.84 Billion USD | 68.727% |
| Exagen Inc. | 29.45 Million USD | -1859.39% |
| Inotiv, Inc. | 165.44 Million USD | -248.856% |
| Guardant Health, Inc. | 336.89 Million USD | -71.316% |
| Biodesix, Inc. | 36.07 Million USD | -1499.795% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -43311.724% |
| Precipio, Inc. | 6.01 Million USD | -9490.528% |
| iSpecimen Inc. | 5.1 Million USD | -11199.285% |
| Natera, Inc. | 492.74 Million USD | -17.132% |
| Aspira Women's Health Inc. | 5.26 Million USD | -10868.415% |
| Standard BioTools Inc. | 50.45 Million USD | -1044.02% |
| 23andMe Holding Co. | 99.37 Million USD | -480.776% |
| Castle Biosciences, Inc. | 174.8 Million USD | -230.171% |
| Personalis, Inc. | 18.2 Million USD | -3069.804% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -4283.035% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -10330.38% |
| OpGen, Inc. | -90.69 Thousand USD | 636479.474% |
| T2 Biosystems, Inc. | -8.17 Million USD | 7164.357% |
| Myriad Genetics, Inc. | 476.4 Million USD | -21.15% |
| ICON Public Limited Company | 1.81 Billion USD | 68.188% |
| NeoGenomics, Inc. | 244.6 Million USD | -135.956% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -4739.494% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 73.645% |
| RadNet, Inc. | 93 Million USD | -520.6% |
| MDxHealth SA | 43.92 Million USD | -1213.843% |
| Psychemedics Corporation | 8.41 Million USD | -6760.311% |
| Illumina, Inc. | 2.74 Billion USD | 78.967% |
| Check-Cap Ltd. | -212 Thousand USD | 272344.34% |
| Twist Bioscience Corporation | 133.34 Million USD | -332.818% |
| DarioHealth Corp. | 5.98 Million USD | -9545.02% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -452.537% |
| Sera Prognostics, Inc. | 96 Thousand USD | -601106.25% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 209632.004% |
| OPKO Health, Inc. | 318.12 Million USD | -81.424% |
| Medpace Holdings, Inc. | 524.5 Million USD | -10.039% |
| Neogen Corporation | 463.9 Million USD | -24.414% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -40384.531% |
| Prenetics Global Limited | 8.82 Million USD | -6436.414% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -113143.953% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -72808.927% |
| Trinity Biotech plc | 19.45 Million USD | -2867.393% |
| Neuronetics, Inc. | 51.7 Million USD | -1016.252% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -72808.927% |